Coronavirus vaccine tracker

Gikan kini sa Internet, pinetsahan October 20 (sa ato pa, bag-o-bag-o pa), sinuwat nila ni Jonathan Corum, Sui-Lee Wee ug Carl Zimmer.

Una sa tanan, atong kutloon ang una nilang pamahayag: “Vaccines typically require years of research and testing before reaching the clinic, but scientists are racing to produce a safe and effective coronavirus vaccine by next year.”

Nga kon maghisgot kita’g vaccine, nagkinahanglan pila ka tuig nga pag-research ug pag-testing niini, una kini muabot sa mga klinika. So, dugay-dugay gyud. Apan, gumikan sa atong kahimtang karon, ang mga scientists nag-dali nga ma-available na ang coronavirus vaccine sa sunod tuig.

Maayo na lang kon aduna nay vaccine sa sunod tuig. Ang problema kon kanus- kini makaabot nganhi sa atong nasud. Pagkakaron, ang researchers nag-testing og ka 48 vaccines in clinical trials on humans, ug laing 89 preclinical vaccines in animals.

Ang mga pag-testing gisugdan sa miaging Enero pinaagi nsa pag-decipher SARS –Cov-2 genome. Ug ang unang vaccine safety trials uban sa tawo, gisugdan sa miaging Marso, ug karon, napulo ang nakaabot na final stages of testing.

Ug ania: “Some of these trials will fail, and others may end without a clear result. But a few vaccines may succeed in stimulating the immune system to produce effective antibodies against the virus.”

Hangtud sa atong pagsulat niini, nagpadayon ang mga pag-testing sa nagkalainlaing vaccine, nga sa atong gikutlo sa unahan, ang uban niini magpakyas, ang uban walay klaro nga resulta, samtang ang uban giisip nga promising o adunay kahigayonan nga molampus.

So, padayon ang atong paghuwat. Ania ang process sa mga pag-testing:  Preclinical testing -  “Scientists test a new vaccine on cells and then give it to animals such as mice or monkeys to see if it produces an immune response. We have confirmed 89 preclinical vaccines in active development.”

Phase 1 Safety trials: “Scientists give the vaccine to a small number of people to test safety and dosage as well as to confirm that it stimulates the immune system.”

Phase 2 Expanded trials: “Scientists give the vaccine to hundreds of people split into groups, such as children and the elderly, to see if the vaccine acts differently in them. These trials further test the vaccine’s safety and ability to stimulate the immune system.”

Phase 3 Efficacy trials: “Scientists give the vaccine to thousands of people and wait to see how many become infected, compared with volunteers who received a placebo. These trials can determine if the vaccine protects against the coronavirus.”

So, ang mga trials sugdan uban sa pipila lang ka tawo, sunod, sa pipila ka gatus, hangtud sa libohan ka tawo

Ug niay pahimangno sa FDA sa America: “In June, the F.D.A. advised vaccine makers that they would want to see evidence that vaccines can protect at least 50 percent of those who receive it. Once a vaccine is licensed, researchers continue to monitor people who receive it to make sure it’s safe and effective.

In the meantime, dinhi sa atong dakbayan, atong padayunon ang pag-observe sa mga health protocols aron atong ma-maintain ang nagkaus-os nga kaso sa na-positive.